Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
1
11%
Ph early_phase_1
1
11%
Ph not_applicable
7
78%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(5)
Terminated(3)

Detailed Status

Completed5
Withdrawn2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
83.3%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (11.1%)
Phase 11 (11.1%)
N/A7 (77.8%)

Trials by Status

terminated111%
withdrawn222%
not_yet_recruiting111%
completed556%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9